Prof. Dr. Michael Bergmann
Specialist in General Surgery and Visceral Surgery
Languages: German/English
My ordination hours
Thursday
9 until 11 am
My goal is to treat you comprehensively and according to international standards. I strive to achieve this goal based on my surgical training at the University Clinic for Surgery in Vienna, specializing in general, transplant, and vascular surgery, as well as surgical intensive care medicine. Within the scope of my work, I consider the following points essential:
1. Information
You need information about your potential procedure to prepare accordingly. I discuss with you your questions regarding the indication and process of your surgery. On demand, I also accompany you in the follow-up care.
2. Specialization
Focusing is a cornerstone of medical quality. My clinical focus lies in colorectal and laparoscopic surgery. The structure of our clinic is designed for specialization and therefore provides optimal conditions because of i) internal continuous evaluation and discussion, ii) the high frequency of procedures within a well-coordinated team and iii) the institutional experience.
3. Interdisciplinarity
Complex medical conditions require interdisciplinary decisions. As a member of the respective boards of the Medical University Vienna, I discuss your conditions with gastroenterologists, oncologists, radiation therapists, radiologists, and pathologists. Years of collaboration with anesthesia and intensive care medicine enable maximum safety during your procedure. Coordination supports this interdisciplinary approach.
4. Scientific understanding
Molecular, translational, and clinical research enable us to better understand diseases and to treat them more precisely today, utilizing “Precision Medicine”. Through constant scientific activity and participation in congresses, I can adhere to these considerations in my medical routine.
Yours Dr. Bergmann
Services
1. Visceral surgery (surgery of the abdomen)
- Colorectal Surgery: Colorectal Carcinoma (CRC)
- Laparoscopic surgery
- Robotic Surgery – Establishment of the program at Med. Univ. Wien (2015)
- Family Burden – Establishment of the Guidelines for Austria (2005)
- Surgery of liver metastases
- Interdisciplinary concepts are developed in the CRC tumor board of the Med. Univ. Wien talked through
- Inflammatory bowel disease (IBD):
- Crohn’s disease (laparoscopic)
- Ulcerative colitis (surgery usually proctocolectomy)
- Interdisciplinary concepts are talked through in the IBD Board of the Med. Univ. Wien
- Diverticulosis/diverticulitis
- Reflux surgery for gastro-esophageal reflux disease (laparoscopic)
- Hernia surgery (laparoscopic)
- Surgery of the bile ducts for gallstones (laparoscopic)
- Abdominal oncological surgery incl. abdominal liposarcomas
2.Gastroscopy and Colonoscopy
Personal Details
Diplomas
- 2017 – Board Certified Robotic Colorectal Surgeon (Europ Academy of Robotic Colorectal Surgery)
- 2008 – Additional Specialist in Visceral Surgery, Austrian Medical Association
- 2003 – Habilitation, Professor of Surgery, Med. Univ. Vienna
- 2000 – Specialist in Surgery, Austrian Medical Association
- 1990 – Dr. med. univ. Universität Wien
Academic Positions
- since 2016 – Senior Physician, Colorectal Team, Dpt. f. General Surgery, MUW
- since 2010 – Head, Surgeon Research Laboratories, Department of Surgery, MUW
- since 2003 – Ao. Univ. Prof., Senior Physician, Dept. of General Surgery, Department of Surgery, MUW, Senior – Group Leader, surgical research laboratories
- since 2000 – Specialist in Surgery, Dept. for General Surgery
- since 1995 – Junior – Group Leader, Surgical Research Laboratories, MUW
- 1994 -2000 – Assistant Physician for Surgery, Dept. for General Surgery
- 1990-1994 – Postdoctoral Fellow, Genetic Engineering of Viruses, Peter Palese, Dept. of Microbiology, Mount Sinai Med School, New York, USA
Boards and Academic Memberships
Clinical Boards:
- Inflammatory bowel disease, Med. Univ. Vienna
- Colorectal tumor Board, Med. Univ. Vienna
Scientific Boards:
- Österreichische Ges. f chir. Forschung since 2010 (President: 2012/13)
- Comprehensive Cancer Center Vienna (Scientific. Advisory council)
- Colorectal Tissue Bank, MUW
- Österreichische Ges. f Molekulare Biotechnologie (ÖGMBT)
Memberships:
- Österreichische Ges f Chirurgie
- Austrian Platform for Personalized Medicine
- European Association of Cancer Research
Research Priorities
- Translational Molecular Oncology, Telomeres
- Tumor Immunologie, Oncolytische Viruses
- Molecular markers for treatment response and prognosis
Congress organization and surgery course since 2012
- 2012 – Bed to Bench-Side in Surgical Oncology – Annual meeting – Society for Surgical Research, Vienna
- 2015 – Host Responses to the Viral Microbiome – Ad-Hoc Kongress- MUW, Wien, Austria
- 2015 – Session “Translational Oncology I+II” – Jahrestagung ÖGMBT, Salzburg, Austria
- 2016 – Session “Translational Oncology I+II” – Jahrestagung ÖGMBT, 12.-14.9., Graz
- 2016 – Laparoscopic Colorectal Training Course, Med Univ. Vienna
- 2017 – Session “Robotic Surgery” – Österr. Chirurgenkongress, Wien
- 2017 – Session „Translational Oncology I+II“ Jahrestagung ÖGMBT, Innsbruck
- 2017 – Biomedical Workshop – Open Med. Inst. – Austrian Acad. of Science, Vienna
- 2017 – Laparoscopic Colorectal Training Course, Med Univ. Vienna
- 2018 – TRIO – „Translational Research and Immun-Oncology“ – MUW Cancer – Comprehensive Center – Meeting, Vienna
Invited Lectures and Chairs
- 2018 – „The Tumor Immune Infiltrate in CRC – A Rational Approach to Therapy“ Precision Medicine in Oncology, Sechenov Med Univeristy, Moscow
- 2018 – „Development of Oncolytic Influenza Viruses“ 5th Immunotherapy of Cancer Conference, Berlin
- 2018 – “Targeting the Immune System – The Clinical Perspective”, Donausymposium, Vienna
- 2018 – „Low Anterior Resection Syndrome “Update –Pelvic Floor, Vienna
- 2018 – „Acute and elective procedures for chronic inflammatory bowel diseases“
- 2017 – 32. Jahrestagung d Med. Ges. Niederösterreichs, St. Pölten
- 2017 – „Rectal carcinoma, organ-preserving concepts“ Chir.-Refresher, Forum Med. Vienna
- 2017 – “The Tumor Immune Infiltrate in CRC”, Maths and Cancer, IMP Seminar, Vienna
- 2017 – 9th Tuscany Retreat on Cancer Research and Apoptosis, Chiusi, Italy
- 2017 – “Oncolytic Virustherapy” Annual Meeting of Austrian Soc. Surg. Research, Schladming
- 2017 – European Federation for Colorectal Cancer, Bi-annual Meeting, Vienna, Austria
- 2017 – Annual Meeting of Austrian Soc. of Surg. Research, Schladming, Austria
- 2017 – European Federation for Colorectal Cancer, Bi-annual Meeting, Vienna, Austria
- 2017 – “Oncolytic Influenza Viruses” Trends in Influenza, St. Petersburg, Russia
- 2017 – Oncolytic Virus Immunotherapy, Cambridge Health Institute, Boston, USA
- 2016 – “Influenza Virus and TLR-3 Stimulation” Dept. Seminar, Dept.of Microbiology, Mount Sinai School of Medicine, New York, USA
- 2016 – Robotic Surgery in Colorectal Cancer Treatment, Ges. der Ärzte, Vienna
- 2016 – Annual Meeting of the Austrian Society of Surgical Research, Schladming, Austria
- 2016 – “Colorectal Cancer” Weill Cornell Seminar in Surgery, Open Medical Institute, Salzburg, Austria
Internationale und nationale Review Aktivitäten
- Grants: Cancer UK, Wissenschaftsfonds der Österr. Nationalbank, Genome British Colombia, Bürgermeisterfonds Wien
- Reviews: Oncotarget, Europ J Clin Investigation, Immun Letters J Mol Medicine, The FEBS Journal, Cancer Res Prevention, Clinical Colorectal Cancer, Europ. Surgery, J Transl Medicine
Awards (incl. members of the working group „Bergmann“)
- 2017 – Best of Biotech, AWS, Vienna; Initis Best Pitch Award
- 2017 – Poster Preis ACO-ASSO – Österr. Ges. f chir. Oncology
- 2017 – 34. Jahrestagung (J. Längle, PhD Student)
- 2017 – Poster Preis, 4th Immunotherapy Cancer Conference, Prag (J. Längle, PhD Student)
- 2015 – Billroth Preis der Österr. Ges. f Chirurgie (Th. Aschacher, PhD Student)
- 2013 – Bester Vortrag, Jahresmeeting Öster. Ges. f chir. Forschung (I. Kuznetsova, PhD Student)
- 2003 – vFWF Habilitation Preis der MUW (M. Bergmann)
Publications
2018
Laengle J, Stift J, Beer A, Bilecz A, Hegedus B, Wolf B, Stremitzer S, Starlinger P, Tamandl D, Pils D, Bergmann MM. DNA damage and ER stress response predicts prognosis and treatment response in bevacizumab-based neoadjuvant-treated patients with colorectal liver metastasis undergoing liver resection, Theranostics, in press IF 8.8
Balber T, Singer J, Berroterán-Infante N, Dumanic M, Fetty L, Fazekas-Singer J, Vraka C, Nics L, Bergmann M, Pallitsch K, Spreitzer H, Wadsak W, Hacker M, Jensen-Jarolim E, Viernstein H and Mitterhauser M. Preclinical in vitro and in vivo evaluation of [18F]FE@SUPPY for cancer PET-imaging: Limitations of a xenograft model for colorectal cancer. Contrast Media and Molecular Imaging 2018
[18F]FEPPA: Improved Automated Radiosynthesis, Binding Affinity, and Preliminary in Vitro Evaluation in Colorectal Cancer. Berroterán-Infante N, Balber T, Fürlinger P, Bergmann M, Lanzenberger R, Hacker M, Mitterhauser M, Wadsak W. ACS Med Chem Lett. 2018 Feb 21;9(3):177-181.
Reshaping a multimode laser beam into a constructed Gaussian beam for generating a thin light sheet. Saghafi S, Haghi-Danaloo N, Becker K, Sabdyusheva I, Foroughipour M, Hahn C, Pende M, Wanis M, Bergmann M, Stift J, Hegedus B, Dome B, Dodt HU. J Biophotonics. 2018 Feb 19. doi: 10.1002/jbio.201700213.
Prognostic value of preoperative neutrophil-to-lymphocyte ratio in Crohn’s disease. Argeny S, Stift A, Bergmann M, Mittlböck M, Maschke S, Yang Y, Chitsabesan P, Riss S. Wien Klin Wochenschr. 2018 Feb 12. doi: 10.1007/s00508-018-1322-3.
2017
Kuznetsova I, Arnold T, Aschacher T, Schwager C, Hegedus B, Garay T, Pleschka S, Egorov A, Bergmann M. Targeting an oncolytic influenza A virus to tumor tissue by elastase. Mol Ther Oncolytics. 2017 Sep 8;7:37-44.
Hock K, Laengle J, Kuznetsova I, Egorov A, Hegedus B, Dome B, Wekerle T, Sachet M, Bergmann M. Oncolytic influenza A virus expressing interleukin-15 decreases tumor growth in vivo. Surgery. 2017 Mar;161(3):735-746 IF 3.9
Holzlechner M, Strasser K, Zareva E, Steinhäuser L, Birnleitner H, Beer A, Bergmann M, Oehler R, Marchetti-Deschmann M. In Situ Characterization of Tissue-Resident Immune Cells by MALDI Mass Spectrometry Imaging. J Proteome Res. 2017 Jan 6;16(1):65-76. IF 4,2
Thannesberger J, Hellinger HJ, Klymiuk I, Kastner MT, Rieder FJJ, Schneider M, Fister S, Lion T, Kosulin K, Laengle J, Bergmann M, Rattei T, Steininger C. Viruses comprise an extensive pool of mobile genetic elements in eukaryote cell cultures and human clinical samples. FASEB J. 2017 May;31(5):1987-2000 IF 5.3
Miller A, Nagy C, Knapp B, Laengle J, Groeger M, Starkl P, Bergmann M, Wagner O and Haschemi A Metabolic configurations of single cells within complex tissue microenvironments. Cell Metabolism 2017 Nov 7;26(5):788-800 IF 18.2
Hofer P, Hagmann M, Brezina S, Dolejsi E, Mach K, Leeb G, Baierl A, Buch S, Sutterlüty-Fall H, Karner-Hanusch J, Bergmann MM, Bachleitner-Hofmann T, Stift A, Gerger A, Rötzer K, Karner J, Stättner S, Waldenberger M, Meitinger T, Strauch K, Linseisen J, Gieger C, Frommlet F, Gsur A. Bayesian and frequentist analysis of an Austrian genome-wide association study of colorectal cancer and advanced adenomas..Oncotarget. 2017 Oct 9;8(58):98623-98634. doi: 10.18632/oncotarget 21697.
2016
Aschacher T, Wolf B, Enzmann F, Kienzl P, Messner B, Sampl S, Svoboda S, Mechtcheriakova D, Holzmann K and Bergmann M LINE-1 induces hTERT and ensures telomere maintenance in tumour cell lines. Oncogene. 2016 Jan 7;35(1):94-104. IF 8.6
Aschacher T, Krokhin A, Kuznetsova I, Längle J, Nebolsin V, Egorov A, Bergmann M. Effect of the antiviral drug Ingavirin® (Imidazolyl ethanamid pentandioic acid) on the interferon status of cell under conditions of viral infection. Epidemiology and Infectious Diseases 2016, 21(4)
Rieder FJ, Gröschel C, Kastner MT, Kosulin K, Laengle J, Zadnikar R, Marculescu R, Schneider M, Lion T, Bergmann M, Kallay E, Steininger C.Human cytomegalovirus infection downregulates vitamin-D receptor in mammalian cells. J Steroid Biochem Mol Biol. 2016 Aug 9. pii: S0960-0760(16)30217-5. IF 4.0
Exner R, Sachet M, Arnold T, Zinn-Zinnenburg M, Michlmayr A, Dubsky P, Bartsch R, Steger G, Gnant M, Bergmann M, Bachleitner-Hofmann T, Oehler R. Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy. Cancer Med. 2016:2350-8. IF 2.9
Zinngrebe J, Rieser E, Taraborrelli L, Peltzer N, Hartwig T, Ren H, Kovacs I, Endres C, Draber P, Darding M, Von Karstadt S, Lembke J, Dome B, Bergmann M, Ferguson BJ, Walczak H, LUBAC deficiency pertubs TLR3 signalling to caue immunodeficiency and autoinflammation. J Exp Med. 2016 Nov 14;213(12):2671-2689 IF 11.8
2015
Exner R, Pulverer W, Diem M, Spaller L, Woltering L, Schreiber M, Wolf B, Sonntagbauer M, Schröder F, Stift J, Wrba F, Bergmann M, Weinhäusel A, Egger G. Potential of DNA methylation in rectal cancer as diagnostic and prognostic biomarkers. Br J Cancer. 2015 Sep 3. doi: 10.1038/bjc.2015.303. [Epub ahead of print] Exner: group member IF 5.0
Weiss R, Laengle J, Sachet M, Shurygina AP, Kiselev O, Egorov A, Bergmann M. Interleukin-24 inhibits influenza A virus replication in vitro through induction of toll-like receptor 3 dependent apoptosis. Antiviral Res. 2015 Nov;123:93-104, IF 4.9
von Karstedt S, Conti A, Nobis M, Montinaro A, Hartwig T, Lemke J, Legler K, Annewanter F, Campbell AD, Taraborrelli L, Grosse-Wilde A, Coy JF, El-Bahrawy MA, Bergmann F, Koschny R, Werner J, Ganten TM, Schweiger T, Hoetzenecker K, Kenessey I, Hegedüs B, Bergmann M, Hauser C, Egberts JH, Becker T, Röcken C, Kalthoff H, Trauzold A, Anderson KI, Sansom OJ, Walczak H. Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis. Cancer Cell. 2015 Apr 13;27(4):561-73. IF 26.3
Schweiger T, Nikolowsky C, Starlinger P, Traxler D, Zimmermann M, Birner P, Hegedüs B, Dome B, Bergmann M, Mildner M, Klepetko W, Hoetzenecker K, Ankersmit HJ. Stromal expression of heat-shock protein 27 is associated with worse clinical outcome in patients with colorectal cancer lung metastases. PLoS One. 2015 Mar 20;10(3):e0120724. IF 3.1
2014
Meshcheryakova A*, Tamandl D*, Bajna E, Stift J, Mittlboeck M, Svoboda M, Heiden D, Stremitzer S, Jensen-Jarolim E, Grünberger T, Bergmann M, Mechtcheriakova D. B cells and ectopic follicular structures: novel players in anti-tumor programming with prognostic power for patients with metastatic colorectal cancer. PLoS One. 2014 Jun 6;9(6):e99008. (Tamandl: group member, * equal contribution) IF 3.9
Kuznetsova I, Shurygina A-P, Wolf B, Wolschek M, Enzmann F, Sansyzbay A Khairullin B, Sandybayev N, Stukova M , Kiselev O, Egorov A, Bergmann M. Adaptive mutation in NEP allows stable transgene expression in a chimeric influenza A virus vector. J Gen. Virol. 2014 Feb;95(Pt 2):337-49 IF 3.6
2013
Weiss R, Sachet M, Zinngrebe J, Aschacher T, Krainer M,Hegedus B, Walczak H, Bergmann M. IL-24 sensitizes tumor cells to TLR3-mediated apoptosis, Cell Death and Differentiation, 2013 Jun;20(6):823-33. IF 8.3
Petricevic B, Längle J, Singer J, Steger G, Bartsch R, Jensen-Jarolim E, Bergmann M. Metastatic disease progression of HER2/neu breast cancer patients does not influence trastuzumab mediated antibody-dependent cell-mediated cytotoxicity or phagocytosis. J Transl. Med. 2013 Dec 12;11:307. IF 4.0
Bonelli M, Ferner E, Göschl L, Blüml S, Hladik A, Karonitsch T, Kiener H, Byrne R, Niederreiter B, Steiner C, Rath E, Bergmann M, Smolen J, Scheinecker C. Abatacept (CTLA-4Ig) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis (RA). Arthritis Rheum. 2013 Mar; 65(3):599-607.
Arnold T, Michlmayr A, Baumann S, Burghuber C, Pluschnig U, Bartsch R, Steger G , Gnant M, Bergmann M, Thomas Bachleitner-Hofmann T, Oehler R. Plasma HMGB-1 after the initial dose of epirubicin/docetaxel in cancer. Europ J Clin Investigation, 2013 Mar;43(3):286- 91.
2012
Aschacher T, Sampl S, Käser L, Bernhard D, Spittler A, Holzmann K, Bergmann M. The combined use of known antiviral reverse transcriptase inhibitors AZT and DDI induce anticancer effects at low concentrations. Neoplasia. 2012 Jan;14(1):44-53. IF 6.3
Schauer D, Starlinger P, Reiter C, Jahn N, Zajc P, Buchberger E, Bachleitner-Hofmann T, Bergmann M, Stift A, Gruenberger T, Brostjan C.Intermediate Monocytes but Not TIE2-Expressing Monocytes Are a Sensitive Diagnostic Indicator for Colorectal Cancer. PLoS One. 2012;7(9):e44450.
2011
Wolschek M, Samm E, Seper H, Sturlan S, Kuznetsova I, Schwager C, Khassidov A, Kittel C, Muster T, Egorov A, Bergmann M. Establishment of a chimeric, replication-deficient influenza A virus vector by modulation of splicing efficiency. J Virol. 2011 Mar;85(5):2469-73.
Riss S, Stremitzer S, Riss K, Mittlböck M, Bergmann M, Stift A. Pelvic organ function and quality of life after anastomotic leakage following rectal cancer surgery. Wien Klin Wochenschr. 2011 Jan; 123(1-2):53-7
Brodowicz T, Amann G, Leithner A, Sztankay A, Kainberger F, Eisterer W, Liegl-Atzwanger B, Rachbauer F, Rath T, Bergmann M, Funovics PT, Ploner F, Windhager R. Consensus diagnosis and therapy of soft tissue sarcoma. Wien Klin Wochenschr. 2012 Feb;124(3-4):85-99.
2010
Riss S, Sift A, Kienbacher C, Dauser B, Haunold I, Kriwanek S, Radlsboek W, Bergmann M. Recurrent-abscess after primary successful endo-sponge assisted treatment of anastomotic leakage after rectal cancer surgery – long term results of a multicenter study. World J Gastroenterol. 2010 Sep 28;16(36):4570-4.
Sturlan S., Stremitzer S, Baumann S, Sachet M, Wolschek M, Egorov A, Bergmann M.
Endogenous expression of proteases in colon cancer cells facilitate influenza A viruses mediated oncolysis. Cancer Biology and Therapy 2010 Sep 2;10(6).592-596
Michlmayr A, Bachleitner-Hofmann T, Baumann S, , Burghuber C, Pluschnig U, Bartsch R, Wenzel C, Altorjai G, Forstner H, Steger G, Gnant M, Bergmann M*, Oehler R.. Modulation of serum complement predicts response to neoadjuvant epirubicin/doxetacel based chemotherapy in breast cancer patients. Br. J. Cancer 2010; Oct 12;103(8):1201-8. (*corresponding author)
Stremitzer S, Bachleitner-Hofmann T, Bachleitner-Hofmann B, Gradl B, Gruenbeck M, Mittlboeck M, , Bergmann M. Treatment of mesh graft infection following abdominal hernia repair. Risk factor evaluation, strategy and influence of the type of mesh used. A retrospective analysis of 478 operations. World J Surg. 2010 Jul;34(7):1702-9.
Riss S, Stift A, Meier M, Haiden E, Grünberger T, Bergmann M. Endo-sponge assisted treatment of anastomotic leakage following colorectal surgery. Colorectal Dis. 2010 Jul;12(Online):e104-8.
Wacheck V, Egorov A, Groiss F, Pfeiffer T, Fuereder T, Hoeflmayer D, Kundi K, Popow-Kraupp T, Redlberger-Fritz M, Mueller CA, Cinatl J, Michaelis M, Geiler J, Bergmann M, Romanova J, Roethl J, Morokutti A, Wolschek M, Ferko B, Seipelt J for the FluVacc EU consortium, Dick-Gudenus R, Muster T. A novel type of live vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1. J. Inf. Dis. 2010, 201: 354-62.
2009
Petricevic B, Wessner B, Sachet M, Vrbanec D, Spittler A, Bergmann, M. CL097, a TLR7/8 ligand, iinhibits TLR-4-Dependent activation of Irak-M and BCL-3 expression. Shock 2009; 32(5): 484-490.
Sachet M, Friedl J, Hassler M, Ploder M, Stary G, Stift A, Bergmann M. Improvement of a dendritic cell-based tumour vaccine by an influenza virus. Eurp. J Clin Investigation 2009; 39(11): 1000-1009.
Sturlan S, Sachet M, Baumann S, Kuznetsova I, Spittler A, Bergmann M. Influenza A Virus Induces an Immediate Cytotoxic Activity in All Major Subsets of Peripheral Blood Mononuclear Cells. PLoS ONE 2009Jan 4(1); e4122
2000 – 2006
Wolf B, Gruber S, Henglmueller S, Kappel S, Bergmann M, Wrba F and Karner-Hanusch J. 2006. Efficiency of the revised Bethesda guidelines for the detection of mutations in mismatch repair genes in Austrian HNPCC patients. Int J Cancer 2006;.118(6):1465-70.
Humer J,Waltenberger A, Grassauer A, Kurz M,Valencak J,Rapberger R, Hahn S, Bergmann M, Löwer R, Wolff K, Muster T, Mayer B and Pehamberger H. Identification of a Melanoma Marker Derived from Melanoma-Associated Endogenous Retroviruses. Cancer Res. 2006; 66: (3): 1658-1663
Wolf B, Henglmueller S, Janschek E, Ilencikova D, Ludwig-Papst C, Bergmann M, Mannhalter C, Wrba F, and Karner-Hanusch J. Spectrum of germ-line MLH1 and MSH2 mutations in Austrian patients with hereditary nonpolyposis colorectal cancer. Wiener klinische Wochenschrift 2005; 117 (7-8) 269-277
Muster T, Rajtarova J, Sachet M, Unger H, Fleischhacker R, Romirer I, Grassauer A, Url A, Garcia-Sastre A, Wolff K, Pehamberger H and Bergmann M. Interferon resistance promotes oncolysis by influenza virus NS1 – deletion mutants. Int J Cancer 2004; 110(1):15-21
Stift A, Prager G, Selzer E, Widder J, Kandioler D, Friedl J, Teleky B, Herbst F, Wrba F and Bergmann M. The early response of p53-dependent proteins during radiotherapy in human rectal carcinoma and in adjacent normal tissue. Int J Oncol. 2003 Nov;23(5):1269-75.
Bergmann M, Gornikiewicz A, Tamandl D, Exner R, Roth E, Fugger R, Gotzinger P and Sautner T. Continuous therapeutic epinephrine but not norepinephrine prolongs splanchnic IL-6 production in porcine endotoxic shock. Shock 2003; 20(6):575-81.
Kandioler D., R. Zwrtek, C. Ludwig, E. Jantschek, M. Ploner, F. Hofbauer, I. Kührer, S. Kappel, F. Wrba, R. Horvath, J. Karner, K. Renner, M. Bergmann, J. Karner-Hanusch, R. Pötter, B. Teleky, R. Jakesz and F. Herbst. TP53 genotype but not p53 immunohistochemical results predicts response to preoperative short trem radiotherapy in rectal cancer. Ann. Surgery 2002; 235:493-498.
Bergmann M., I. Romirer, M. Sachet, R. Fleischhacker, A. García-Sastre, P. Palese, K, Wolff, H. Pehamberger, R. Jakesz and T. Muster. A genetically engineered influenza A virus with ras-dependent oncolytic properties. Cancer Res. 2001; 61: 8188-8193.
Spittler A., T. Sautner, A. Gornikiewicz, N. Manhart, R. Oehler, M. Bergmann, R. Függer and E. Roth. Postoperative glycyl-glutamine infusion reduces immunosuppression: partial prevention of the surgery induced decrease in HLA-DR expression on monocytes. Clin Nutr 2001; 20:37-42.
Gornikiewicz, A., T. Sautner, C. Brostjan, B. Schmierer, R. Függer, E. Roth, F. Mühlbacher, and M. Bergmann. Catecholamines upregulate lipopolysaccaride-induced IL-6 production in human microvascular endothelial cells. FASEB-J 2000; 14: 1093-1100.
Öehler R., G. Weingartmann, N. Manhart, U. Salzer, M. Meissner, W. Schlegel, A. Spittler, M. Bergmann, D. Kandioler, C. Oismüller, H.M. Struse and E. Roth. Polytrauma induces increased expression of pyruvate kinase in neutrophils. Blood 2000; 95, 1086-1092.
Böhmig G., T. Saemann, M. Bergmann, B. Watschinger, H. Regele, T. Windhager, F. Mühlbacher, W.H. Hörl. and G. Zlabinger. Long-term evaluation of proliferative donor antigen-specific reactivity in cadaveric kidney transplant recipients. Transplant International 2000; 13: 187-193
Guidelines, Book chapter, Invited Comments and Reviews, Articles in Med. Popular Press
Primas C, Vogelsang H, Bergmann M. Morbus Crohn – Was erwartet der Kliniker von der Radiologie. Der Radiologe. in press
Müller K, Wolf B, Aschacher T, Bergmann M. Line-1 and Telomeres. Frontiers in Bioscience 2018 Jan 1;23:1310-1319 IF 3.9
Aschacher T, Enzmann F, Salameh O, Bergmann M. Telomere Biology and Thoaracic Aortic Aneurysm. Int J Mol Sci. 2017 Dec 21;19(1) IF 3.2
Nowikowsky K, Bergmann M. Autophagy regulates apoptosis on the level of the death inducing signaling complex. FEBS J 284 (2017): 1967-69 IF 4,2
Bergmann M, Gruber ES, Starlinger P, Bachleitner-Hofmann-T. Ein Roboter als Assitenzarzt. Forum Darmkrebs 1/2017: 8
Bachleitner-Hofmann T, Stalinger P, Gruber ES, Binter A, Bergmann M. Stellenwert der Roboterchirurgie in der minimal invasiven Therapie des Rektumkarzinoms. Hämatologie und Onkologie 2 JATROS 2017: 88-90
Bergmann M, Längle J. Onkolytische Virustherapie bei Malignomen. Infekiologie & Gastroenterologie-Hepatologie 4/15 JATROS 2016: 21-23
Kristo I, Stift A, Bergmann M, Riss S. Surgical recurrence in Crohn’s disease: Are we getting better? World J Gastroenterol. 2015 May 28;21(20):6097-100.
Brodowicz T, Amann G, Leithner A, Sztankay A, Kainberger F, Eisterer W, Liegl-Atzwanger B, Rachbauer F, Rath T, Bergmann M, Funovics PT, Ploner F, Windhager R. Consensus diagnosis and therapy of soft tissue sarcoma. Wien Klin Wochenschr. 2012 Feb;124(3-4):85-99
Bergmann M et al. Standard operating procedures colorectal cancer. Medical Univierstiy of Vienna. Internal guidelines. 2009
Bergmann M, Wolf B and Karner-Hanusch J. Hereditary colorectal cancer – guidelines for clinical routine. Eur Surg 2006; 38/1: 59-62
Muster T and Bergmann M. 2005. Influenza A viruses with deletions the NS1 gene – a rational design for oncolytic virues. In „Viral Therapy of Human Cancer “ Eds: J.G. Szinkovics and J.C. Horvath. Marcel Dekker, New York. pp 575-596.
Bergmann M and Sautner T. Immunologische Nebenwirkungen von Katecholaminen. Intensiv-News 2002; 6 (2):4-5.
Bergmann M and Sautner T. Immunomodulatory effects of vasoactive catecholamines. Wiener klinische Wochenzeitschrift. Wien Klin Wochenschr. 2002; Sep 30;114(17-18):752-
Patents & Media
Patents
- 1) Genetically engineered attenuated viruses Patent Numbers PCT/US93/03615 filed Dec 1994, US Patent 6,022,726 issued Feb 2000 Assignee: MOUNT SINAI MEDICAL SCHOOL, NEW YORK Inventor(s): PALESE P, ENAMI M, MUSTER T, BERGMANN M.
- 2) New reassortant influenza-A virus comprising gene segments of seasonal or pandemic strain origin, a polymerase basic protein-1 gene segment, and a polymerase gene segment, useful e.g. as vaccine to prevent influenza virus infection Patent Number(s): WO2010070098-A1, Publ. Date: 24-Jun-2010, Assignee: AVIR GREEN HILLS BIOTECHNOLOGY RES DEV Inventor(s): BERGMANN M; EGOROV A; MUSTER T, ROETHLE E, ROMANOVA J, WOLSCKEK M
- 3) New replication deficient influenza virus comprises a modified nonstructural protein (NS) segment, useful for treating tumor. Patent Number(s): WO2009007244-A2; Publ. Date: 15-Jan-2009 Assignee: AVIR GREEN HILLS BIOTECHNOLOGY RES DEV; UNIV WIEN MEDIZINISCHE; Inventor(s): BERGMANN M; EGOROV A; KITTEL C, MUSTER T, WOLSCHEK M
- 4) New linear expression construct that is free of any amplification and/or selection sequences, useful for preparing a composition for treating or preventing infectious diseases, e.g., avian influenza virus infection . Patent Number(s): WO2009000891-A2; Publ. Date: 31 Dec 2008 Assignee: AVIR GREEN HILLS BIOTECHNOLOGY RES DEV; UNIV WIEN MEDIZINISCHE Inventor(s): WOLSCHEK M; EGOROV A; BERGMANN M, MUSTER M, KITTEL C
- 5) Pharmaceutical composition useful for inducing specific immune response against antigen e.g. tumor antigens or antigens of infectious pathogens like viruses, comprises antigen and adjuvant, which is apathogenic virus . Patent Number(s): WO2007016715-A2; Publ Date 15 Feb 2007 Assignee: GREENHILLS BIOTECHNOLOGY RES DEV TRADE G Inventor(s): SACHET M; BERGMANN M; MUSTER T, EGOROV A
- 6) Stable influenza A virus vector. Europ. Appl. Nr. 12184041.7, Filing 12 Sept 2012 Assignee: Med. Univ Vienna Inventors: BERGMANN M, KUZNETSOVA I
- 7) Tumor cell Apoptosis. Europ. Appl Nr. 12184040.9, Filing: 12 Sept 2012 Assignee: Med Univ. Vienna Inventors: BERGMANN M, WEISS R
Blog Posts
My ordination hours
Thursday
9 until 11 am
